Gender differences in the insulin-like growth factor axis response to a glucose load

Acta Physiologica

Volumn 187, Issue 3, 2006, Pages 371-378

  Flanagan, D E ^a   Holt, R I G ^b,e   Owens, P C ^c   Cockington, R J ^c   Moore, V M ^c   Robinson, J S ^c   Godsland, I F ^d   Phillips, D I W ^b  

^a DERRIFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

Gender; Glucose; Insulin; Insulin sensitivity; Insulin like growth factor

Indexed keywords

GLUCOSE; INSULIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AUSTRALIA; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET RESTRICTION; FEMALE; HUMAN; HUMAN EXPERIMENT; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; MEDICAL EXAMINATION; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEX DIFFERENCE;

ADULT; BLOOD GLUCOSE; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INFUSIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MALE; SEX CHARACTERISTICS;

EID: 33745013158     PISSN: 17481708     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2006.01581.x     Document Type: Conference Paper

References (38)

1. Alpha B. Cox L. Crowther N. Clark P.M. Hales C.N. 1992. Sensitive amplified immunoenzymometric assays (IEMA) for human insulin and intact proinsulin. Eur J Clin Chem Clin Biochem 30, 27 32.
2. Amiel S.A. Sherwin R.S. Hintz R.L. Gertner J. Press C.M. Tamborlane W.V. 1984. Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 33, 1175 1179.
3. Bar R.S. Clemmons D.R. Boes M. et al. 1990. Transcapillary permeability and subendothelial distribution of endothelial and amniotic fluid insulin-like growth factor binding proteins in the rat heart. Endocrinology 127, 1078 1086.
4. Bergman R.N. 1989. Toward physiological understanding of glucose tolerance. Minimal-model approach. Diabetes 38, 1512 1527.
5. Bergman R.N. Ider Y. Bowden C. Cobelli C. 1979. Quantitative estimation of insulin sensitivity. Am J Physiol 236, E667 E677.
6. Brismar K. Fernqvist-Forbes E. Wahren J. Hall K. 1994. Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79, 872 878.
7. Brismar K. Hilding A. Lindgren B. 1995. Regulation of IGFBP-1 in humans. Prog Growth Factor Res 6, 449 456.
8. Carroll P.V. Umpleby M. Ward G.S. Imuere S. Alexander E. Dunger D. Sonksen P.H. Russell-Jones D.L. 1997. rhIGF-I administration reduces insulin requirements, decreases growth hormone secretion, and improves the lipid profile in adults with IDDM. Diabetes 46, 1453 1458.
9. Clausen J.O. Borch-Johnsen K. Ibsen H. Pedersen O. 1998. Analysis of the relationship between fasting serum uric acid and the insulin sensitivity index in a population-based sample of 380 young healthy Caucasians. Eur J Endocrinol 138, 63 69.
10. Crossey P.A. Jones J.S. Miell J.P. 2000. Dysregulation of the insulin/IGF binding protein-1 axis in transgenic mice is associated with hyperinsulinemia and glucose intolerance. Diabetes 49, 457 465.
11. Da Silva Xavier G. Qian Q. Cullen P.J. Rutter G.A. 2004. Distinct roles for insulin and insulin-like growth factor-1 receptors in pancreatic beta-cell glucose sensing revealed by RNA silencing. Biochem J 377 Pt 1 149 158.
12. Dall R. Longobardi S. Ehrnborg C., et al. 2000. The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 85, 4193 4200.
13. Duan C. Xu Q. 2005. Roles of insulin-like growth factor (IGF) binding proteins in regulating IGF actions. Gen Comp Endocrinol 142, 44 52. Epub 2005 Feb 5.
14. Flanagan D.E. Moore V.M. Godsland I.F. Cockington R.A. Robinson J.S. Phillips D.I. 1999. Reduced foetal growth and growth hormone secretion in adult life. Clin Endocrinol 50, 735 740.
15. Flanagan D.E. Moore V.M. Godsland I.F. Cockington R.A. Robinson J.S. Phillips D.I. 2000. Fetal growth and the physiological control of glucose tolerance in adults: a minimal model analysis. Am J Physiol Endocrinol Metab 278, E700 E706.
16. Frystyk J. Grofte T. Skjaerbaek C. Orskov H. 1997. The effect of oral glucose on serum free insulin-like growth factor-I and -II in health adults. J Clin Endocrinol Metab 82, 3124 3127.
17. Holt R.I. Simpson H.L. Sonksen P.H. 2003. The role of the growth hormone-insulin-like growth factor axis in glucose homeostasis. Diabet Med 20, 3 15.
18. Johnson T.R. Blossey B.K. Denko C.W. Ilan J. 1989. Expression of insulin-like growth factor I in cultured rat hepatocytes: effects of insulin and growth hormone. Mol Endocrinol 3, 580 587.
19. Mohan S. 1993. Insulin-like growth factor binding proteins in bone cell regulation. Growth Regul 3, 67 70.
20. Mohan S. Baylink D.J. 1991. Bone growth factors. Clin Orthop Relat Res 263, 30 48.
21. Nyomba B.L. Berard L. Murphy L.J. 1997. Free insulin-like growth factor I (IGF-I) in healthy subjects: relationship with IGF-binding proteins and insulin sensitivity. J Clin Endocrinol Metab 82, 2177 2181.
22. Olchovsky D. Bruno J.F. Wood T.L. et al. 1990. Altered pituitary growth hormone (GH) regulation in streptozotocin-diabetic rats: a combined defect of hypothalamic somatostatin and GH-releasing factor. Endocrinology 126, 53 61.
23. Ooi G.T. Tseng L.Y. Tran M.Q. Rechler M.M. 1992. Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats. Mol Endocrinol 6, 2219 2228.
24. Rajkumar K. Murphy L.J. 1999. Enhanced gluconeogenesis and hepatic insulin resistance in insulin-like growth factor binding protein-1 transgenic mice. Biochim Biophys Acta 1426, 491 497.
25. Rajkumar K. Krsek M. Dheen S.T. Murphy L.J. 1996. Impaired glucose homeostasis in insulin-like growth factor binding protein-1 transgenic mice. J Clin Invest 98, 1818 1825.
26. Ricart W. Fernandez-Real J.M. 2001. No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance. Obes Res 9, 631 636.
27. Sandhu M.S. Heald A.H. Gibson J.M. Cruickshank J.K. Dunger D.B. Wareham N.J. 2002. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359, 1740 1745.
28. Sesti G. Sciacqua A. Cardellini M. Marini M.A. Maio R. Vatrano M. Succurro E. Lauro R. Federici M. Perticone F. 2005. Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance. Diabetes Care 28, 120 125.
29. Sjogren K. Wallenius K. Liu J.L. Bohlooly-Y M. Pacini G. Svensson L. Tornell J. Isaksson O.G.P. Ahrén B. Jansson J.-O. Ohlsson C. 2001. Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism. Diabetes 50, 1539 1545.
30. Sönksen P.H. Soeldner J.S. Gleason R.E. Boden G. 1973. Abnormal serum growth hormone responses in genetically potential diabetic male patients with normal oral glucose tolerance: evidence for an insulin like action of growth hormone in vivo. Diabetologia 9, 426 437.
31. Suikkari A.M. Koivisto V.A. Rutanen E.M. Yki-jarvinen h. Karonen S.L. Seppala M. 1988. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab 66, 266 272.
32. Swan J.W. Walton C. Godsland I.F. 1994. Assessment of insulin sensitivity in man: a comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. Clin Sci Colch 86, 317 322.
33. Undén A.L. Elofsson S. Brismar K. 2005. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study. Clin Endocrinol (Oxf) 63, 94 102.
34. Vaessen N. Heutink P. Janssen J.A. et al. 2001. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50, 637 642.
35. Walton C. Godsland I.F. Proudler A.J. Felton C. Wynn V. 1992. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol 262, E755 E762.
36. Woods K.A. Camacho-Hubner C. Bergman R.N. Barter D. Clark A. Savage M.O. 2000. Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 85, 1407 1411.
37. Yakar S. Liu J.L. Fernandez A.M. Wu Y. Schally A.V. Frystyk J. Chernausek S.D. Mejia W. Le Roith D. 2001. Liver-specific IGF-1 gene deletion leads to muscle insulin insensitivity. Diabetes 50, 1110 1118.
38. Zenobi P.D. Graf S. Ursprung H. Froesch E.R. 1992. Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion. J Clin Invest 89, 1908 1913.